Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Basch

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
International Immunology|February 1, 1992
T560: an (H-2b x H-2a) F1 hybrid, phosphorylcholine (PC)-binding, murine B cell lymphoma that bears receptors for IgA and IgG, presents antigen and secretes IL-4T D Rao, A A Maghazachi, A M Faria, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1978
Thymopoietin enhances the allogeneic response and cyclic GMP levels of mouse peripheral, thymus-derived lymphocytesG H Sunshine, R S Basch, R G Coffey, et al.
Immunology|December 1, 1980
Terminal deoxynucleotidyl transferase expression in a Thy-l alloantigen variant lymphoma cell lineT F Bumol, E F Retzel, S D Douglas, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
International Immunology|February 1, 1992
T560: an (H-2b x H-2a) F1 hybrid, phosphorylcholine (PC)-binding, murine B cell lymphoma that bears receptors for IgA and IgG, presents antigen and secretes IL-4T D Rao, A A Maghazachi, A M Faria, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1978
Thymopoietin enhances the allogeneic response and cyclic GMP levels of mouse peripheral, thymus-derived lymphocytesG H Sunshine, R S Basch, R G Coffey, et al.
Immunology|December 1, 1980
Terminal deoxynucleotidyl transferase expression in a Thy-l alloantigen variant lymphoma cell lineT F Bumol, E F Retzel, S D Douglas, et al.
Pageof 7